The stem cell research sector is growing more than twice as fast (7%) as the global research average (2.9%), according to a new report. The study, which examined the growth and development of the stem cell field as a whole, also closely examined the embryonic stem (ES) cell and induced pluripotent stem (iPS) cell research landscape.
Recent Posts
- Stem cells provide a potent treatment for frailty
- Cracking a ‘holy grail’ challenge in cancer cell therapy
- New Bio-Implant for Spinal Cord Repair
- Seattle jury awards $24M in lawsuit against stem cell center
- Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
- After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
